Discovering and developing transformative therapies for people with advanced liver disease
Ambys Medicines is a biotechnology company dedicated to capitalizing on advances in liver biology and regenerative medicines to develop therapies for serious liver diseases. Founded by world-renowned experts in liver disease and regenerative medicine, Ambys is pioneering the application of novel modalities including cell and gene therapy, and targeted drug therapy, to meet the urgent need for treatments that have potential to restore liver function and prevent the progression to liver failure across multiple liver diseases that are untreatable or poorly treated today. Ambys was launched in 2018 by Third Rock and Takeda Pharmaceuticals.
Year Invested: 2018
Location: Redwood City, CA